<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="97349">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01775657</url>
  </required_header>
  <id_info>
    <org_study_id>20120228-01H</org_study_id>
    <nct_id>NCT01775657</nct_id>
  </id_info>
  <brief_title>Digital Versus Analog Pleural Drainage Following Pulmonary Resection</brief_title>
  <acronym>DiVA Phase II</acronym>
  <official_title>Digital Versus Analog Pleural Drainage Following Pulmonary Resection (Phase II)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ottawa Hospital Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ottawa Hospital Research Institute</source>
  <oversight_info>
    <authority>Canada: Ethics Review Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the impact of continuous, digital pulmonary air leak monitoring on
      the duration of pleural drainage after lung resection in patients with and without a
      pulmonary air leak on postoperative day 1.

      Patients undergoing pulmonary resection who fit the inclusion criteria will be identified
      pre-operatively. Patients within two groups (air leak and no air leak) will be randomized to
      receive either the analogue system or the digital system. Both systems are approved for use
      in hospitals by Health Canada.  There will be 80 patients in each group (digital and
      analogue).

      Hypothesis: Continuous, quantitative monitoring of PAL following lung resection leads to
      more efficient chest tube management as measured by an improvement in primary outcomes.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research</study_design>
  <primary_outcome>
    <measure>Time to first pleural drain removal</measure>
    <time_frame>Over 24 hours post-op</time_frame>
    <safety_issue>No</safety_issue>
    <description>Patient must still have pleural drain, 24 hours post op, with no plans to remove before 36 hours post op.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall length of hospitalization</measure>
    <time_frame>Up to 5 days post-op (average)</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Pulmonary Air Leak</condition>
  <condition>Lobectomy</condition>
  <condition>Wedge Resection</condition>
  <condition>Segmentectomy</condition>
  <arm_group>
    <arm_group_label>Air leak present - Analogue</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients randomized to Pleur Evac (Analogue drainage) monitoring system, air leak present.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Air leak absent - Analogue (Pleur Evac)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients randomized to Pleur Evac (Analogue drainage) monitoring system, no air leak present</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Air leak present - Digital (Thopaz)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with an air leak present, randomized to Thopaz (digital drainage) monitoring system.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Air leak absent - Digital (Thopaz)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients randomized to digital system, no air leak present.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Thopaz (Digital drainage)</intervention_name>
    <arm_group_label>Air leak present - Digital (Thopaz)</arm_group_label>
    <arm_group_label>Air leak absent - Digital (Thopaz)</arm_group_label>
    <other_name>Thopaz, Medela Switzerland</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pleur Evac (Analogue drainage)</intervention_name>
    <arm_group_label>Air leak present - Analogue</arm_group_label>
    <arm_group_label>Air leak absent - Analogue (Pleur Evac)</arm_group_label>
    <other_name>Pleur Evac A-6002-08, Teleflex Inc, Reseach Triangle Park, NC, USA</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age â‰¥ 18 years

          -  Pulmonary resection for Benign or Neoplastic diagnosis  (includes lobectomy,
             segmentectomy or wedge resection)

          -  Patient must be alert, and oriented to time, person and place

        Exclusion Criteria:

          -  Tension pneumothorax

          -  Traumatic or iatrogenic pneumothorax

          -  Primary or recurrent spontaneous pneumothorax awaiting surgery

          -  Pneumonectomy patient (history of or current treatment)

          -  Inability to provide informed consent:

          -  Altered mental status from narcotics,  general anesthesia, severe systemic illness
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sebastien Gilbert, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ottawa Hospital Research Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sebastien Gilbert, MD</last_name>
    <phone>613-737-8899</phone>
    <phone_ext>74033</phone_ext>
    <email>sgilbert@ohri.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ottawa Hospital, General Campus</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1H8L6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sebastien Gilbert, MD</last_name>
      <phone>613-737-8899</phone>
      <phone_ext>74033</phone_ext>
    </contact>
    <investigator>
      <last_name>Anna McGuire, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrew JE Seely, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sebastien Gilbert, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Donna Maziak, MD, FRCSC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sudhir Sundaresan, MD, FRCSC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Farid Shamji, MD, FRCSC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Villeneuve P James, MD, FRCSC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 2, 2014</lastchanged_date>
  <firstreceived_date>November 29, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pulmonary air leak</keyword>
  <keyword>Thopaz</keyword>
  <keyword>digital</keyword>
  <keyword>analog</keyword>
  <keyword>randomized</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
